La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

SaintMed Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Viroje Vasusuttikulkant

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	no data
Proprietà del CEO	8.5%
Durata media del management	2.3yrs
Durata media del Consiglio di amministrazione	Nessun dato

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Viroje Vasusuttikulkant

no data

Mandato

Dr. Viroje Vasusuttikulkant serves as Chief Executive Officer and Director at Saintmed Public Company Limited and served as its Acting Chief Financial Officer since April 1, 2022 until April 8, 2022.

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Viroje Vasusuttikulkant	CEO & Director	no data	Nessun dato	8.52% THB 72.2m
Prapassorn Patamapinun	Chief Financial Officer	2.3yrs	Nessun dato	Nessun dato
Sorajja Boonprasit	COO & Director	no data	Nessun dato	12.07% THB 102.3m
Chonchanok Sumrongkij	Accounting Manager	1.3yrs	Nessun dato	Nessun dato
Rhamon Vasusuttikulkant	Chief Sales and Marketing Officer	2.3yrs	Nessun dato	9.83% THB 83.3m
Kittathum Nguansamarng	Chief of HR and IT & Director	no data	Nessun dato	5.73% THB 48.6m
Taveesak Boonprasit	Chief Service Officer & Director	no data	Nessun dato	5.78% THB 49.0m

2.3yrs

Durata media

Gestione esperta: Il team dirigenziale di SMD è considerato esperto (durata media dell'incarico 2.3 anni).

SaintMed Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

SaintMed Public Company Limited, Annual General Meeting, Apr 26, 2024

Saintmed Public Company Limited Appoints Prapassorn Patamapinum as Chief Financial Officer

Less than half of directors are independent

Saintmed Public Company Limited Appoints Pipop Udorn as Members of Audit Committee

Less than half of directors are independent

Saintmed Public Company Limited Announces Chief Finance Officer Changes

Recent updates

Second quarter 2024 earnings released: EPS: ฿0.025 (vs ฿0.13 in 2Q 2023)

Now 20% undervalued after recent price drop

First quarter 2024 earnings released: ฿0.05 loss per share (vs ฿0.036 profit in 1Q 2023)

Upcoming dividend of ฿0.15 per share

Full year 2023 earnings released: EPS: ฿0.35 (vs ฿1.32 in FY 2022)

SaintMed Public Company Limited, Annual General Meeting, Apr 26, 2024

Investor sentiment improves as stock rises 27%

Upcoming dividend of ฿0.15 per share at 20% yield

Third quarter 2023 earnings released: EPS: ฿0.054 (vs ฿0.30 in 3Q 2022)

Saintmed Public Company Limited Announces Dividend for the Operating Period from 01 January 2023 to 30 September 2023, Payable on 13 December 2023

Saintmed Public Company Limited (SET:SMD) announces an Equity Buyback for 22,000,000 shares, representing 9.79% for THB 120 million.

Second quarter 2023 earnings released: EPS: ฿0.13 (vs ฿0.39 in 2Q 2022)

First quarter 2023 earnings released: EPS: ฿0.036 (vs ฿0.61 in 1Q 2022)

Saintmed Public Company Limited Approves Dividend for the Year 2022, Payable on May 19, 2023

Upcoming dividend of ฿0.50 per share at 14% yield

Third quarter 2022 earnings released: EPS: ฿0.30 (vs ฿0.85 in 3Q 2021)

Saintmed Public Company Limited Appoints Prapassorn Patamapinum as Chief Financial Officer

Less than half of directors are independent

Upcoming dividend of ฿0.25 per share

Second quarter 2022 earnings released: EPS: ฿0.39 (vs ฿0.38 in 2Q 2021)

Saintmed Public Company Limited Announces Dividend for the Operating Period from 01 January 2022 to 30 June 2022, Payable on 14 September 2022

Saintmed Public Company Limited Appoints Pipop Udorn as Members of Audit Committee

First quarter 2022 earnings released: EPS: ฿0.64 (vs ฿0.048 in 1Q 2021)

Less than half of directors are independent

Saintmed Public Company Limited Announces Chief Finance Officer Changes

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Saintmed Public Company Limited, Annual General Meeting, Apr 26, 2022

Third quarter 2021 earnings released: EPS ฿0.89 (vs ฿0.069 in 3Q 2020)

Second quarter 2021 earnings released: EPS ฿0.39 (vs ฿0.069 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ฿0.05 (vs ฿0.98 in 1Q 2020)

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media